Proprietary Product Portfolio

Hovione’s product portfolio consists of innovative, proprietary drug products in the areas of Dermatology, Ophthalmology, and Respiratory.

Hovione’s product portfolio is comprised of known Active Pharmaceutical Ingredients (APIs) which have been formulated to meet patient needs by increasing safety, improving compliance or expanding access by following the FDA 505(b)2 regulatory pathway. We focus on the fields of dermatology, ophthalmology and respiratory and target new routes of administration, expansion of indications and improved delivery. Hovione develops its products through Phase 1/2 and seeks partners for completion of the clinical development, regulatory approval, and commercialization.

Product List
 

DERMATOLOGY
Product Condition Dosage Form Formulation
Development		 Non-Clinical Clinical Phase Partnering Clinical Trial
HY01 Rosacea Topical Gel Completed Completed Phase 2b completed Available Clinical Design
OPHTHALMOLOGY
Product Condition Dosage Form Formulation
Development		 Non-Clinical Clinical Phase Partnering Clinical Trial
HY02 Blepharitis
Dry eye disease		 Sterile ointment Completed On-going Phase 2b
on-going		 Available Clinical Design

 

RESPIRATORY
Product Condition Dosage Form Formulation
Development		 Non-Clinical Clinical Phase 1/2 Partnering
IH11 Asthma TwinCaps® DPI On-going     Available

 

To learn more about our projects please contact our team.

 

Related Files

Also in 独自製品ライセンス

Partnering Opportunities

Hovione offers the opportunity for early partnering under flexible collaboration structures such as Licensing, Investment and Co-development business models.

Page
Read more